GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Greenyn Biotechnology Co Ltd (ROCO:6846) » Definitions » Price-to-Free-Cash-Flow

Greenyn Biotechnology Co (ROCO:6846) Price-to-Free-Cash-Flow : 57.34 (As of May. 16, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Greenyn Biotechnology Co Price-to-Free-Cash-Flow?

As of today (2024-05-16), Greenyn Biotechnology Co's share price is NT$78.90. Greenyn Biotechnology Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$1.38. Hence, Greenyn Biotechnology Co's Price-to-Free-Cash-Flow Ratio for today is 57.34.

The historical rank and industry rank for Greenyn Biotechnology Co's Price-to-Free-Cash-Flow or its related term are showing as below:

ROCO:6846' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 9.46   Med: 13.39   Max: 56.99
Current: 50.03

During the past 5 years, Greenyn Biotechnology Co's highest Price-to-Free-Cash-Flow Ratio was 56.99. The lowest was 9.46. And the median was 13.39.

ROCO:6846's Price-to-Free-Cash-Flow is ranked worse than
61.47% of 218 companies
in the Biotechnology industry
Industry Median: 31.84 vs ROCO:6846: 50.03

Greenyn Biotechnology Co's Free Cash Flow per Share for the three months ended in Mar. 2024 was NT$1.10. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was NT$1.38.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Greenyn Biotechnology Co was -83.20% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -48.30% per year.

During the past 5 years, Greenyn Biotechnology Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 21.40% per year. The lowest was -48.30% per year. And the median was -13.45% per year.


Greenyn Biotechnology Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Greenyn Biotechnology Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenyn Biotechnology Co Price-to-Free-Cash-Flow Chart

Greenyn Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
- - - 9.54 54.82

Greenyn Biotechnology Co Quarterly Data
Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.33 18.57 14.15 54.82 -

Competitive Comparison of Greenyn Biotechnology Co's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Greenyn Biotechnology Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Greenyn Biotechnology Co's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Greenyn Biotechnology Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Greenyn Biotechnology Co's Price-to-Free-Cash-Flow falls into.



Greenyn Biotechnology Co Price-to-Free-Cash-Flow Calculation

Greenyn Biotechnology Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=78.90/1.376
=57.34

Greenyn Biotechnology Co's Share Price of today is NT$78.90.
Greenyn Biotechnology Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1.38.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Greenyn Biotechnology Co  (ROCO:6846) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Greenyn Biotechnology Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Greenyn Biotechnology Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenyn Biotechnology Co (ROCO:6846) Business Description

Traded in Other Exchanges
N/A
Address
5th Floor, No 43 Keya Road, Daya District, Taichung, TWN
Greenyn Biotechnology Co Ltd has developed Insumate patented sequenced peptide, Antromax Antrodia cinnamomea mycelia, and Zymologist fermented liquid.

Greenyn Biotechnology Co (ROCO:6846) Headlines

No Headlines